The work of improving global health is a collaborative effort. It takes many partners working together to bring their global perspectives and valuable insights from diverse health-related constituencies to the table. USP has many such partners, most of whom are also USP Convention Member Organizations.
Poor quality medicines are the source of an alarming, but often overlooked global health crisis. A report from the International Policy Network estimates that 700,000 people die every year from fake anti-malarial and tuberculosis drugs alone.
Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) marked a major milestone in the fight against substandard and poor quality drugs by acheiving internationally recognized ISO 17025 accreditation.
Access to quality care and medicines is an integral part of public health. For USP, an organization that creates and promotes public standards for medicines and foods, quality and access are two sides of the same coin and in fact the absence of either one actually threatens effectiveness of medical care around the world.
USP Visiting Scientist Santiago Gallardo Dávila talks with USP about his work as a pharmaceutical chemist at the Mexican Pharmacopeia, and the intersection between chemistry and global health.
What are your chances of getting a fake medicine? 1 in 100? 1 in 10? Or 1 in 2? You may or may not think much about fake medicines, but the fact is they exist in practically every corner of the globe. The good news is that we can fight fake medicines together, through public awareness and communication sharing.